As many as 1 in 3 coronavirus patients could experience neurological or psychological after-effects

The effects of the coronavirus do not end when patients "leave the hospital," Wes Ely, a pulmonologist and critical care physician at Vanderbilt University Medical Center, told Stat News. And one of the ways COVID-19 appears to linger in recovered hospitalized patients is its effect on neurological and psychological well-being — Stat reports as many as 1 in 3 recovering patients could experience after-effects in those areas.
This "COVID fog" makes patients feel like they "can't think," writes Stat. Since the early days of the pandemic in China and Europe, clinicians have described patients who continue to suffer from things like nerve damage, cognitive impairment, depression, and anxiety after their release. It's unclear if and when those folks will see their conditions improve, but experts are using their experience treating other pathogens and delirium after Intensive Care Unit stays, using results from brain autopsies and interviews with patients to get a sense of what's really going on.
"We would say that perhaps between 30 percent and 50 percent of people with an infection that has clinical manifestations are going to have some form of mental health issues," said Teodor Postolache, professor of psychiatry at the University of Maryland School of Medicine. "That could be anxiety or depression, but also nonspecific symptoms that include fatigue, sleep, and waking abnormalities, a general sense of not being at your best, not being fully recovered in terms of the abilities of performing academically, occupationally, potentially physically." Read more at Stat News.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Festival of Sport announces exciting media partnership with The Week Junior
Festival of Sport, the UK’s premier family-friendly sports festival, has officially teamed up with The Week Junior as its exclusive media partner.
By The Week Junior Published
-
Bergerac: 'darker' reboot of the eighties crime drama
The Week Recommends Irish actor Damien Molony takes over from John Nettles as the Jersey detective
By The Week UK Published
-
Pamela Anderson is 'transfixing' in The Last Showgirl
The Week Recommends 'Quietly touching' film about a Las Vegas showgirl facing the end of her career
By The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published